Famomax 20 mg tablet
Generic: Famotidine
Company: Beximco Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated September 7, 2024.
Generic: Famotidine
Company: Beximco Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated September 7, 2024.
Sorted by price per tablet. Ask your pharmacist before you switch brands.
Prices as listed on BestinMeds.
Advertisement
What this medicine is for, how to take it, and what to watch for.
Read the full Famotidine guide
Famotidine is indicated in- Gastric ulcer Duodenal ulcer Anastomotic ulcer Acute stress ulcer Reflux esophagitis and Zollinger-Ellison syndrome. Famotidine is also indicated for the treatment of acute gastritis, chronic gastritis in the acute exacerbation stage.
Tablet: For gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastro-intestinal hemorrhage, reflux esophagitis and Zollinger-Ellison syndrome: Usual dose for adults: Famotidine 20 mg twice daily (after breakfast and after supper or before bed time) or Famotidine 40 mg can be administered orally once daily at bed time. For the treatment of acute gastritis, chronic gastritis in acute exacerbation stage: Usual dosage for adults is Famotidine 20 mg orally twice a day (after breakfast and after supper or before bed time). Also Famotidine 40 mg can be orally administered once a day (before bed time), dosage should be adjusted according to age and symptoms. Most ulcer patients heal within 4-8 weeks. For maintenance therapy the recommended oral dose is 20 mg once daily. Or, as directed by the registered physician. Powder for Suspension: Gastroesophageal Reflux Disease(GERD):
Eruption, constipation, diarrhoea, dry mouth, nausea, vomiting, tachycardia, high blood pressure, headache, drowsiness or insomnia may rarely occur.
The drug should be used in the minimum required amount depending upon the conditions of the diseases. The drug should be administered carefully with elderly patients, patients with renal failure and hepatic disorders.
Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Caution should be exercised when Famotid is administered to a nursing woman.
Famotidine is a histamine H2-receptor antagonist. Famotidine completely inhibits the action of histamine on H2- receptors of parietal cell. It inhibits basal, overnight and pentagastrin stimulated gastric acid secretion. The H2- receptor antagonist activity of Famotidine is slowly reversible, since the drug dissociates slowly from H2-receptor.
No clinically important drug interactions have been identified. Famotidine does not interact with the cytochrome P450-linked drug-metabolizing enzyme system.
Renal impairment: Dose reduction or extended dosing intervals are necessary (see Dosage and Administration), as Famotidineine is primarily eliminated by the kidneys and accumulation increases the risk of CNS side effects.Hepatic impairment: No specific dosage adjustment is generally required, as Famotidineine undergoes minimal hepatic metabolism; use with routine caution.Elderly: No dosage adjustment is required based on age alone, but elderly patients (especially those with reduced renal function) are at increased risk of CNS adverse effects and should be monitored closely.Pediatric patients: Use as per weight-based dosing guidance (see Pediatric Uses); safety and efficacy in neonates and infants below 3 months of age for indications beyond GERD have not been well established.Pregnancy and lactation: See "Pregnancy and Lactation" section above.Pediatric UsesFamotidineine is approved for use in pediatric patients for GERD and related acid-related conditions, with dosing based on age and body weight:Age groupTypical dosing (as established/guideline-based)Neonates (0-3 months)Safety and efficacy not well established; used cautiously under specialist supervision only if clearly needed, with reduced/adjusted doses3 months to under 1 yearApproximately 0.5 mg/kg/dose, once or twice daily, for GERD, under medical supervision1 to 16 yearsApproximately 0.5-1 mg/kg/dose twice daily (weight-based, per indication), not to exceed adult maximum doses≥40 kg or ≥12 yearsMay generally follow adult dosing recommendationsPediatric doses of Famotidineine should always be determined and supervised by a pediatrician, as safety and efficacy have not been established for all indications and all age groups.
Symptoms of Famotidineine overdose may include confusion, drowsiness, dizziness, hypotension, and transient adverse effects similar to those seen at therapeutic doses, though they are typically not life-threatening. In case of a suspected overdose, seek immediate medical attention or contact a poison control center. Treatment is generally symptomatic and supportive; unabsorbed material may be removed from the gastrointestinal tract by standard measures under medical supervision, and hemodialysis may be considered in severe cases, particularly with renal impairment, since Famotidineine is efficiently removed by dialysis. Do not attempt to manage an overdose at home without medical guidance.
Famotidineine belongs to the therapeutic class of Histamine H2-receptor antagonists (H2 blockers), a group of medicines used to reduce gastric acid secretion in the treatment of acid-related disorders of the upper gastrointestinal tract.Histamine H2-receptor antagonist (H2 blocker); Anti-ulcer / gastric acid secretion inhibitor.
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.
Advertisement
No other Famomax products are listed yet.
Advertisement